Affiliation:
1. Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, 17489 Greifswald, Germany
Abstract
In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To predict the behaviour of an esophageal-applied dosage form, it is necessary to simulate the site of application in a biorelevant way. The aim of this work was to develop two test setups for an esophageal peristalsis model which was described in a previous study. Different parameters such as flow rate, peristalsis, angle of inclination or mucous membrane were varied or introduced into the model. A stimulated and unstimulated modus were developed and tested with two different dosage forms. The time until the dosage form was cleared from the in vitro model was shorter with the stimulated than with the unstimulated modus. Also, esophageal-applied films had a prolonged transit time compared to a viscous syrup. The modification of the simulated esophageal surface made it possible to estimate the retention time of the dosage forms. It could be demonstrated that the residence time of a dosage form depends on different parameters affecting each other.
Subject
Polymers and Plastics,General Chemistry
Reference27 articles.
1. Eosinophilic esophagitis: Incidence and prevalence;Moawad;Gastrointest. Endosc. Clin.,2018
2. Eosinophilic esophagitis in a patient with vigorous achalasia;Landres;Gastroenterology,1978
3. Eosinophilic esophagitis: Current concepts in diagnosis and treatment;Delgado;World J. Gastroenterol.,2019
4. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference;Dellon;Gastroenterology,2018
5. Washington, N., Washington, C., and Wilson, C. (2003). Physiological Pharmaceutics Barriers to Drug Absorption, Taylor and Francis Inc.. [2nd ed.].